Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7655312rdf:typepubmed:Citationlld:pubmed
pubmed-article:7655312lifeskim:mentionsumls-concept:C0013227lld:lifeskim
pubmed-article:7655312lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:7655312lifeskim:mentionsumls-concept:C0029266lld:lifeskim
pubmed-article:7655312lifeskim:mentionsumls-concept:C0001962lld:lifeskim
pubmed-article:7655312lifeskim:mentionsumls-concept:C1144854lld:lifeskim
pubmed-article:7655312lifeskim:mentionsumls-concept:C0021941lld:lifeskim
pubmed-article:7655312lifeskim:mentionsumls-concept:C2728259lld:lifeskim
pubmed-article:7655312pubmed:issue1lld:pubmed
pubmed-article:7655312pubmed:dateCreated1995-9-29lld:pubmed
pubmed-article:7655312pubmed:abstractTextAssessment of therapeutic orientation is a significant problem in substance abuse program evaluation. This study reports the initial results of a new approach to measuring treatment orientation through a self-report survey that focuses on distinctive features of substance abuse treatment orientations. The Drug and Alcohol Program Treatment Inventory (DAPTI) assesses treatment goals and activities specific to eight orientations: AA/12 Step, Therapeutic Community, Cognitive-Behavioral, Insight/Psychodynamic, Rehabilitation, Dual Diagnosis, Medical and Marital/Family Systems. We present findings from a nationwide assessment of 327 Veterans Administration (VA) Substance Abuse treatment programs that demonstrate promising subscale internal consistency, discriminant validity, and concurrent validity. In addition, the DAPTI distinguishes between programs with independently verified orientations and between inpatient, extended care, outpatient, and methadone maintenance programs. The DAPTI may be helpful in systematically assessing differences in treatment orientations between different types of programs, such as inpatient, community residential, and outpatient care.lld:pubmed
pubmed-article:7655312pubmed:languageenglld:pubmed
pubmed-article:7655312pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7655312pubmed:citationSubsetIMlld:pubmed
pubmed-article:7655312pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7655312pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7655312pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7655312pubmed:statusMEDLINElld:pubmed
pubmed-article:7655312pubmed:issn0899-3289lld:pubmed
pubmed-article:7655312pubmed:authorpubmed-author:MoosR HRHlld:pubmed
pubmed-article:7655312pubmed:authorpubmed-author:PetersonK AKAlld:pubmed
pubmed-article:7655312pubmed:authorpubmed-author:SwindleR WRWlld:pubmed
pubmed-article:7655312pubmed:authorpubmed-author:ParadiseM JMJlld:pubmed
pubmed-article:7655312pubmed:issnTypePrintlld:pubmed
pubmed-article:7655312pubmed:volume7lld:pubmed
pubmed-article:7655312pubmed:ownerNLMlld:pubmed
pubmed-article:7655312pubmed:authorsCompleteYlld:pubmed
pubmed-article:7655312pubmed:pagination61-78lld:pubmed
pubmed-article:7655312pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7655312pubmed:meshHeadingpubmed-meshheading:7655312-...lld:pubmed
pubmed-article:7655312pubmed:meshHeadingpubmed-meshheading:7655312-...lld:pubmed
pubmed-article:7655312pubmed:meshHeadingpubmed-meshheading:7655312-...lld:pubmed
pubmed-article:7655312pubmed:meshHeadingpubmed-meshheading:7655312-...lld:pubmed
pubmed-article:7655312pubmed:meshHeadingpubmed-meshheading:7655312-...lld:pubmed
pubmed-article:7655312pubmed:meshHeadingpubmed-meshheading:7655312-...lld:pubmed
pubmed-article:7655312pubmed:meshHeadingpubmed-meshheading:7655312-...lld:pubmed
pubmed-article:7655312pubmed:meshHeadingpubmed-meshheading:7655312-...lld:pubmed
pubmed-article:7655312pubmed:meshHeadingpubmed-meshheading:7655312-...lld:pubmed
pubmed-article:7655312pubmed:meshHeadingpubmed-meshheading:7655312-...lld:pubmed
pubmed-article:7655312pubmed:meshHeadingpubmed-meshheading:7655312-...lld:pubmed
pubmed-article:7655312pubmed:meshHeadingpubmed-meshheading:7655312-...lld:pubmed
pubmed-article:7655312pubmed:meshHeadingpubmed-meshheading:7655312-...lld:pubmed
pubmed-article:7655312pubmed:meshHeadingpubmed-meshheading:7655312-...lld:pubmed
pubmed-article:7655312pubmed:meshHeadingpubmed-meshheading:7655312-...lld:pubmed
pubmed-article:7655312pubmed:year1995lld:pubmed
pubmed-article:7655312pubmed:articleTitleMeasuring substance abuse program treatment orientations: the Drug and Alcohol Program Treatment Inventory.lld:pubmed
pubmed-article:7655312pubmed:affiliationDepartment of Veterans Affairs Medical Center, Palo Alto, CA, USA.lld:pubmed
pubmed-article:7655312pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7655312pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:7655312pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7655312lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7655312lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7655312lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7655312lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7655312lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7655312lld:pubmed